Your browser doesn't support javascript.
loading
Modified enzyme multiplied immunoassay technique of methotrexate assay to improve sensitivity and reduce cost.
Shi, Xiaoping; Gao, Hui; Li, Zhong; Li, Jinghua; Liu, Yang; Li, Lujuan; Zhang, Qi.
Affiliation
  • Shi X; Pharmacy Department of Dalian Children's Hospital, No.154, Zhongshan Road, Dalian City, 116012, Xigang District, China.
  • Gao H; Hematology Ward of Dalian Children's Hospital, No.154, Zhongshan Road, Dalian City, 116012, Xigang District, China.
  • Li Z; Pharmacy Department of Dalian Children's Hospital, No.154, Zhongshan Road, Dalian City, 116012, Xigang District, China. Lzong159@139.com.
  • Li J; Pharmacy Department of Dalian Children's Hospital, No.154, Zhongshan Road, Dalian City, 116012, Xigang District, China.
  • Liu Y; Pharmacy Department of Dalian Children's Hospital, No.154, Zhongshan Road, Dalian City, 116012, Xigang District, China.
  • Li L; Pharmacy Department of Dalian Children's Hospital, No.154, Zhongshan Road, Dalian City, 116012, Xigang District, China.
  • Zhang Q; Pharmacy Department of Dalian Children's Hospital, No.154, Zhongshan Road, Dalian City, 116012, Xigang District, China.
BMC Pharmacol Toxicol ; 20(1): 3, 2019 Jan 09.
Article in En | MEDLINE | ID: mdl-30626430
ABSTRACT

BACKGROUND:

Methotrexate is an important component in many chemotherapy protocols. The blood concentration of Methotrexate is used to determine the regimen of folinic acid. However, the lower limit of Siemens assay kit is 0.30 µmol/L in China. This study extended the limit from 0.3 to 0.05 µmol/L and reduced the test cost by optimizing the parameters of Enzyme Multiplied Immunoassay Technique assay.

METHODS:

Parameters of Enzyme Multiplied Immunoassay Technique assay were modified to decrease the volume of reagents A and B. Then a standard curve with a new custom set of calibrators was prepared to detect low concentration. Intra-day and inter-day imprecision were assessed by control material and samples. The linearity of the modified assay was verified by analyzing a range of quality controls with known concentration from 0.05 to 1.00 µmol/L. At last, the same samples were tested by modified Enzyme Multiplied Immunoassay Technique assay and Liquid Chromatography-tandem Mass Spectrometry assay respectively. A simple linear regression was performed to verify the validity of the modified Enzyme Multiplied Immunoassay Technique assay.

RESULTS:

Intra-day and inter-day imprecision show good reproducibility at all levels (0.05, 0.12, 0.43, 0.82 µmol/L). The linearity equation of modified assay was y = 0.9913x + 0.0046, in which y was the mean of measured concentration and x was the target concentration (R2 = 0.9994). In the range of 0.05-10.00 µmol/L, correlation between the Modified assay and Liquid Chromatography-tandem Mass Spectrometry assay was significant (r = 0.9968). In the range of 0.30-10.00 µmol/L, the correlation between modified and commercial assays was significant (r = 0.9987) as well.

CONCLUSIONS:

The modified assay enhanced the sensitivity of Siemens VIVA-E to 0.05 µmol/L. In addition, the test number of a reagent Kit increased from 140 to 210. This means the cost of detection was reduced about 30%.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Methotrexate / Enzyme Multiplied Immunoassay Technique / Antimetabolites, Antineoplastic Type of study: Diagnostic_studies / Health_economic_evaluation Limits: Child / Humans Language: En Journal: BMC Pharmacol Toxicol Year: 2019 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Methotrexate / Enzyme Multiplied Immunoassay Technique / Antimetabolites, Antineoplastic Type of study: Diagnostic_studies / Health_economic_evaluation Limits: Child / Humans Language: En Journal: BMC Pharmacol Toxicol Year: 2019 Document type: Article